Atezolizumab for the First-Line Treatment of Non-small Cell Lung Cancer (NSCLC): Current Status and Future Prospects
Author:
Publisher
Frontiers Media SA
Subject
Cancer Research,Oncology
Reference37 articles.
1. The roles of the new negative T cell costimulatory pathways in regulating autoimmunity;Khoury;Immunity,2004
2. Tissue expression of PDL-1 mediates peripheral T cell tolerance;Keir;J Exp Med.,2006
3. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion;Dong;Nat Med.,2002
4. B7-H1 pathway and its role in the evasion of tumor immunity;Dong;J Mol Med.,2003
5. Preclinical pharmacokinetics, pharmacodynamics, tissue distribution, and tumor penetration of anti-PD-L1 monoclonal antibody, an immune checkpoint inhibitor;Deng;MAbs,2016
Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Phage Display as a Medium for Target Therapy Based Drug Discovery, Review and Update;Molecular Biotechnology;2024-06-01
2. Evaluation of the Prognostic Impact of SP263-Evaluated PD-L1 Expression in Patients with Stage III Non-Small Cell Lung Cancer (NSLC) Treated with Radio-Chemotherapy;Biomedicines;2024-03-19
3. Neoadjuvant therapy in non-small cell lung cancer: basis, promise, and challenges;Frontiers in Oncology;2023-12-08
4. Designed Endocytosis-Triggering Proteins mediate Targeted Degradation;2023-08-21
5. Natural epidithiodiketopiperazine alkaloids as potential anticancer agents: Recent mechanisms of action, structural modification, and synthetic strategies;Bioorganic Chemistry;2023-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3